Additionally, HLF downregulation could promote multiple-organ distant metastases in NSCLC through PPAR/NF-κB signaling; thus, HLF might serve as a prognostic biomarker of NSCLC [47]. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.